RxDoctor Payments DataLook up a doctor →

Milton Hom

Corneal and Contact Management · Azusa, CANPI 1326158478

Payments from drug & device makers

$998,723in general payments, 2019–2025

Across 532 payments — averaging $1877.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Bausch & Lomb Americas Inc.$395K
  • AbbVie$173K
  • Bausch & Lomb, A Division Of Bausch Health US, LLC$170K
  • Novartis$115K
  • Kala Pharmaceuticals, Inc.$104K
  • Harrow Eye, LLC$26K
  • plus $15K from 12 others
$567,365in research payments, 2019–2025

Across 34 payments — averaging $16,687 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • AbbVie$507K
  • Shire North American Group Inc$43K
  • Bausch Health US, LLC$17K

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$998,723 in reported general payments places this provider in the 95th percentile of 140 corneal and contact management providers in California.

See all corneal and contact management providers in California

Other corneal and contact management in Azusa

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →